아리바이오LAB Stock: price and insider trades · South Korea

아리바이오LAB is a listed company. Its insiders report their share dealings to DART (FSS). Over the twelve months to 25 October 2026, 2 filings were filed, from 2 insiders.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

For context, the typical company on the same exchange (median of 2,650 companies) published 7 filings over the same period, against 2 filings here.

There has been no open-market purchase by an insider of 아리바이오LAB for at least a year.

Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.